microdosing glp 1 for menopause GLP-1 Perimenopause: Benefits & Risks GLP-1 Medications, Menopause, and Metabolic

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist administered subcutaneously for type 2 diabetes management (Ozempic) and chronic weight management (Wegovy)

Morning dosing for sublingual drops Sublingual drops do not have the same strict empty-stomach requirement as tablets because the medication absorbs through oral mucous membranes rather than through the stomach lining

You eat less because you genuinely want less, not because food makes you uncomfortable

It is notoriously sensitive to how and when it is taken, typically requiring administration on an empty stomach, separate from other medications and certain foods, to ensure optimal absorption

Currently licensed standard-dose diabetes tablets in the UK generally yield lower average weight loss results than dedicated weight loss injections